|
|
Volumn 105, Issue 4, 2002, Pages
|
|
Coating stents with antirestenotic drugs: the blunderbuss or the magic bullet?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DEOXYRIBOZYME;
DNA BINDING PROTEIN;
EARLY GROWTH RESPONSE FACTOR 1;
EGR1 PROTEIN, HUMAN;
EGR1 PROTEIN, RAT;
IMMEDIATE EARLY PROTEIN;
MESSENGER RNA;
RAPAMYCIN;
TRANSCRIPTION FACTOR;
ANIMAL;
DRUG DELIVERY SYSTEM;
GENE TARGETING;
GENETICS;
GRAFT OCCLUSION;
HUMAN;
METABOLISM;
METHODOLOGY;
NOTE;
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY;
RAT;
STENT;
SWINE;
ANGIOPLASTY, BALLOON;
ANIMALS;
DNA, CATALYTIC;
DNA-BINDING PROTEINS;
DRUG DELIVERY SYSTEMS;
EARLY GROWTH RESPONSE PROTEIN 1;
GENE TARGETING;
GRAFT OCCLUSION, VASCULAR;
HUMANS;
IMMEDIATE-EARLY PROTEINS;
RATS;
RNA, MESSENGER;
SIROLIMUS;
STENTS;
SWINE;
TRANSCRIPTION FACTORS;
|
|
EID: 0037192355
PISSN: None
EISSN: 15244539
Source Type: Journal
DOI: 10.1161/circ.105.4.e29 Document Type: Note |
|
Times cited : (9)
|
|
References (0)
|
